Header cover image

Spanish Buy the Dip

Results

1

1 new

Companies which have seen a dip in the last 7 days after continued gains and are looking undervalued based on Snowflake checks.

1 companies

Oryzon Genomics

Market Cap: €227.1m

A clinical stage biopharmaceutical company, engages in the discovery and development of epigenetics-based therapeutics for patients with cancer and CNS (central nervous system) disorders.

New

ORY

€2.88

7D

-14.9%

1Y

75.8%